A/C ENZYMATIC VITAMIN B6 ASSAY— 510(k) K111260

Name: FDA 510(k) clearance K111260
Creator: U.S. Food and Drug Administration
Published: 2012-07-26

Substantially Equivalent

Anticancer, Inc.

FDA 510(k) clearance K111260 for A/C ENZYMATIC VITAMIN B6 ASSAY, Substantially Equivalent on 2012-07-26. Applicant: Anticancer, Inc.. Device class: 2.

Clearance details

Applicant: Anticancer, Inc.
Product code: Code CDD
Device class: Class 2
Regulation: 21 CFR 862.1810
Advisory panel: Clinical Chemistry
Date received: 2011-05-05
Decision date: 2012-07-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CDD

view all

K233541 — ARCHITECT Active-B12 (Holotranscobalamin)2024-07-31
K223289 — Access Vitamin B122022-12-23
K190298 — DxA 5000, DxI 800 Access Immunoassay System, Access Ferritin, Access Folate, Access TSH (3rd IS), Access Vitamin B122019-10-04
K192064 — LIAISON Vitamin B122019-10-02
K172133 — ADVIA Centaur Active-B12 (Holotranscobalamin) (AB12) Assay2017-10-27

More clearances from Anticancer, Inc.

view all

K080851 — A/C PORTABLE ENZYMATIC HOMOCYSTEINE ASSAY2008-10-10
K030754 — A/C ENZYMATIC HOMOCYSTEINE ASSAY2003-07-11

Data sourced from openFDA. This site is unofficial and independent of the FDA.